このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Acute Effects of Myofascial Release on Squat Jump Performance

2026年11月11日 更新者:Doç.Dr.Ömer Şevgin、Uskudar University

Investigation of the Acute Effects of Myofascial Release Technique Applied to Lower Extremity Muscles on Squat Jump Performance and Lower Extremity Kinematics: A Randomized Controlled Trial

This randomized controlled trial will investigate the acute (immediate) effects of a single session of manual myofascial release applied to lower extremity muscles on squat jump height and lower extremity joint kinematics in healthy young adults aged 18-40 years. Sixty volunteers will be randomly assigned to a myofascial release group or a control (rest) group. After a standardized warm-up, all participants will perform three maximal squat jumps. The intervention group will then receive standardized bilateral manual myofascial release to predetermined lower extremity muscle groups, while the control group will rest for an equivalent period. Squat jump testing will then be repeated under identical conditions. Jump height will be measured with the validated smartphone application My Jump 2, and hip, knee and ankle kinematics during the jump will be recorded with a Microsoft Kinect-based markerless motion analysis system.

調査の概要

状態

まだ募集していません

詳細な説明

Background: Squat jump (SJ) is a widely used field test of lower extremity explosive strength that isolates concentric force production by eliminating the countermovement. Myofascial release (MFR) is commonly used in physiotherapy and sports settings to improve range of motion and flexibility; however, its acute effects on strength, power and explosive performance vary according to technique, duration and targeted muscle group, and the effects of standardized manual MFR applied to specific lower extremity regions on jump performance and joint kinematics have not been adequately investigated.

Design: Two-arm, parallel-group, randomized controlled trial with a pre-test/post-test design. Participants will be randomly allocated 1:1 to the MFR group or the control group using a computer-generated randomization list. The study will be conducted at the Üsküdar University Physiotherapy and Rehabilitation Application and Research Center (ÜSTFİZYOTEM), Istanbul, Türkiye.

Procedures: After informed consent, demographic and descriptive data (age, sex, height, body mass, dominant lower limb, physical activity habits, injury and surgical history) will be recorded. All participants will receive an explanation of the SJ technique and a standardized warm-up. Baseline testing: participants will perform three maximal vertical squat jumps from a predetermined knee-flexion starting position with hands on hips and without countermovement, with adequate rest between trials. Jump height (cm) will be measured using the My Jump 2 smartphone application from high-speed video (take-off and landing frames). Simultaneously, hip, knee and ankle joint motion during the jump will be recorded with a Microsoft Kinect-based motion analysis system. Intervention: the MFR group will receive standardized bilateral manual myofascial release to four lower extremity muscle groups (gluteal, quadriceps, hamstring and triceps surae) using a sustained cross-hand release technique (90 seconds per muscle group per limb; total application time 12 minutes), with pressure direction, participant position and application region standardized across participants. The control group will rest quietly for an equivalent duration and will receive no manual therapy. Post-testing: immediately after the intervention or rest period, the SJ test will be repeated under identical conditions (same device, technique, position and environment).

Outcomes: The primary outcome is the change in squat jump height (cm, My Jump 2) from pre- to post-intervention. Secondary outcomes are sagittal-plane hip, knee and ankle kinematics during the squat jump obtained from the Kinect-based system: peak flexion (hip, knee) and peak dorsiflexion (ankle) angles in the starting squat position, joint angles at take-off, joint range of motion during propulsion (take-off angle minus starting angle) and, as exploratory variables, peak joint angular extension velocities during the propulsive phase.

Sample size: 60 participants (30 per group). Analysis: Normality will be assessed with the Shapiro-Wilk test, histograms and Q-Q plots. Descriptive data will be presented as mean ± SD or median (IQR) and counts (%). The primary outcome will be analyzed with a two-way mixed-design repeated-measures ANOVA (group × time), with the group × time interaction as the main indicator of the acute effect of MFR; post-hoc pairwise comparisons with correction for multiple comparisons will be performed when appropriate. Non-parametric alternatives will be used if assumptions are violated. Secondary kinematic variables will be analyzed in the same way. Significance will be set at p < 0.05; effect sizes and 95% confidence intervals will be reported.

研究の種類

介入

入学 (推定)

60

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究場所

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

18年~40年 (大人)

健康ボランティアの受け入れ

はい

受講資格のある性別

全て

説明

Inclusion Criteria:

  • Age 18-40 years
  • Volunteering to participate and signing the informed consent form
  • Ability to perform the squat jump test independently and safely
  • No pain or functional limitation markedly restricting active lower extremity movement or jump performance
  • Ability to understand and follow verbal instructions during the study

Exclusion Criteria:

  • Lower extremity or lumbar surgery within the last 6 months
  • Muscle, tendon, ligament or joint injury of the lower extremity within the last 3 months that may affect jump performance
  • Acute lower extremity or lumbar pain at the time of assessment
  • Neurological, musculoskeletal or cardiovascular disease that may affect jump performance or safe exercise
  • Open wound, active infection, serious dermatological condition or any other contraindication in the myofascial release application area
  • Development of pain, dizziness, dyspnea or any symptom preventing safe continuation during testing or application
  • Failure to complete the study protocol or voluntary withdrawal

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:基礎科学
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:独身

武器と介入

参加者グループ / アーム
介入・治療
実験的:Myofascial release group

Standardized warm-up and baseline squat jump testing, followed by a single session of standardized bilateral manual myofascial release applied to predetermined lower extremity muscle groups, followed by post-intervention squat jump testing under identical conditions.

A single session of manual myofascial release applied bilaterally by a physiotherapist to four lower extremity muscle groups: gluteal muscles (prone), quadriceps (supine), hamstrings (prone) and triceps surae (prone). Technique: sustained cross-hand myofascial release with slow, low-load pressure applied in the direction of tissue restriction until a tissue release is felt, held for 90 seconds per muscle group per limb (4 muscle groups × 2 limbs × 90 s = 12 minutes total), without oil or lubricant. Order of application (gluteal → hamstring → triceps surae → quadriceps), participant position, direction of pressure and duration are standardized for all participants. Applied immediately after baseline squat jump testing; post-testing follows within 2 minutes after the application.

他の名前:
  • Myofascial release technique; MFR
介入なし:Control (rest) group

Standardized warm-up and baseline squat jump testing, followed by 12 minutes of quiet seated rest (equivalent to the myofascial release application time), followed by post-test squat jump testing under identical conditions. No manual therapy is applied.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Change in squat jump height
時間枠:Baseline (pre-intervention) and immediately after the intervention/rest period (approximately 15-20 minutes after baseline, same session)

Vertical squat jump height (cm) measured with the My Jump 2 smartphone application from high-speed video using flight time (take-off and landing frames). Best of three trials (or mean, as predefined in the protocol). Higher values indicate better jump performance.

Baseline (pre-intervention) and immediately after the intervention/rest period (approximately 15-20 minutes after baseline, same session)

二次結果の測定

結果測定
メジャーの説明
時間枠
Change in peak hip flexion angle in the starting squat position
時間枠:Baseline and immediately after the intervention/rest period (same session)

Sagittal-plane peak hip flexion angle (degrees) in the predetermined starting squat position immediately before propulsion, recorded with a Microsoft Kinect-based markerless motion analysis system; mean of three trials.

Baseline and immediately after the intervention/rest period (same session)
Change in peak knee flexion angle in the starting squat position
時間枠:Baseline and immediately after the intervention/rest period (same session)

Sagittal-plane peak knee flexion angle (degrees) in the starting squat position, Kinect-based system; mean of three trials.

Baseline and immediately after the intervention/rest period (same session)
Change in sagittal-plane ankle, hip and knee kinematics during the squat jump
時間枠:Baseline and immediately after the intervention/rest period (same session)

Composite set of sagittal-plane kinematic variables recorded with a Microsoft Kinect-based markerless motion analysis system (mean of three trials): (a) peak ankle dorsiflexion angle in the starting squat position (degrees); (b) hip, knee and ankle joint angles at the instant of take-off, defined as the last frame of foot contact (degrees); (c) hip, knee and ankle range of motion during the propulsive phase, calculated as take-off angle minus starting-position angle (degrees); and (d) peak hip, knee and ankle angular extension velocities during the propulsive phase (degrees/second), reported as exploratory given the 30 Hz sampling rate.

Baseline and immediately after the intervention/rest period (same session)

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

捜査官

  • スタディチェア:Parsa KEİHANİ、Üsküdar University

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年12月15日

一次修了 (推定)

2027年3月1日

研究の完了 (推定)

2027年3月1日

試験登録日

最初に提出

2026年11月11日

QC基準を満たした最初の提出物

2026年11月11日

最初の投稿 (実際)

2026年11月17日

学習記録の更新

投稿された最後の更新 (実際)

2026年11月17日

QC基準を満たした最後の更新が送信されました

2026年11月11日

最終確認日

2026年11月1日

詳しくは

本研究に関する用語

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

未定

IPD プランの説明

De-identified individual participant data may be made available from the principal investigator upon reasonable request after publication of the main results.

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する